Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Prenatal retinoic acid increases lipofibroblast expression in hypoplastic rat lungs with experimental congenital diaphragmatic hernia.
[congenital diaphragmatic hernia]
Prenatal
administration
of
all-trans
retinoic
acid
(
ATRA
)
has
been
shown
to
stimulate
alveolarization
in
nitrofen-induced
pulmonary
hypoplasia
(
PH
)
associated
with
congenital
diaphragmatic
hernia
(
CDH
)
.
Lipid-containing
interstitial
lipofibroblasts
(
LIFs
)
,
characterized
by
adipocyte
differentiation-related
protein
(
ADRP
)
,
play
a
critical
role
in
alveolar
development
by
coordinating
lipid
homeostasis
.
Previous
studies
have
demonstrated
that
ATRA
positively
affects
LIF
expression
in
developing
lungs
.
We
hypothesized
that
pulmonary
LIF
expression
is
increased
after
prenatal
ATRA
treatment
in
the
nitrofen
model
of
CDH
-associated
PH
.
Timed-pregnant
rats
were
treated
with
nitrofen
or
vehicle
on
E
9
.
5
,
followed
by
injection
of
ATRA
or
placebo
on
E
18
.
5
,
E
19
.
5
,
and
E
20
.
5
.
Fetal
lungs
were
dissected
on
E
21
.
5
and
divided
into
Control
+
Placebo
,
Control
+
ATRA
,
Nitrofen
+
Placebo
,
and
Nitrofen
+
ATRA
.
Pulmonary
gene
expression
levels
of
ADRP
were
analyzed
by
quantitative
real-time
polymerase
chain
reaction
,
and
LIF
expression
was
investigated
by
ADRP
immunohistochemistry
,
oil-
red
-
O-
,
and
immunofluorescence-
double
-staining
.
Relative
mRNA
expression
of
pulmonary
ADRP
was
significantly
increased
in
Nitrofen
+
ATRA
compared
to
Nitrofen
+
Placebo
(
0
.
31
±
0
.
02
vs
.
0
.
08
±
0
.
01
;
P
<
0
.
0001
)
.
ADRP
immunoreactivity
and
oil-
red
-
O-
staining
were
markedly
increased
in
alveolar
interstitium
of
Nitrofen
+
ATRA
compared
to
Nitrofen
+
Placebo
.
Immunofluorescence-
double
-staining
confirmed
markedly
increased
LIF
expression
in
alveolar
walls
of
Nitrofen
+
ATRA
compared
to
Nitrofen
+
Placebo
.
Increased
LIF
expression
after
prenatal
treatment
with
ATRA
in
nitrofen-induced
PH
suggests
that
ATRA
may
have
a
therapeutic
potential
in
attenuating
CDH
-associated
PH
by
stimulating
alveolar
development
.
Diseases
Validation
Diseases presenting
"prenatal treatment"
symptom
congenital diaphragmatic hernia
congenital toxoplasmosis
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom